EUVIMEDEUVIMED entdecken
Crossref

Evaluation of Genetic Marker Polymorphisms (MTHFRC677T and ABCC2 C) for Predicting Methotrexate Toxicity in Psoriasis Patients in Egypt: A Case‐Control Study

Asmaa Mohammad Sayed Ahmed iD, Mervat Hamdy Abdel Salam, Eman A F Zohairy, Mohamed H M El-Komy, Marwa Abdelgwad, Hussein A Nasr, Abrar Roshdy Abouelkheir

Journal of Biochemical and Molecular Toxicology · 2025

DOI: 10.1002/jbt.70537 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biochemical and Molecular Toxicology, 2025. Verfasst von Asmaa Mohammad Sayed Ahmed und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Forensic Medicine and Clinical Toxicology, Faculty of Medicine, Cairo University, Cairo, Egypt. Hauptthemen laut MEDLINE: Methotrexate, Methylenetetrahydrofolate Reductase (NADPH2), ATP-Binding Cassette, Sub-Family C Proteins, Polymorphism, Single Nucleotide. Die Arbeit nennt 39 Literaturangaben. Gefördert von: Faculty of medicine cairo university; Cairo University & self-funded..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Methotrexate is an antineoplastic agent prescribed in various treatment protocols, particularly for psoriasis. Studies on toxicogenomic and clinical data suggest that polymorphism in genes involved in folate metabolism are linked to varying individual responses to methotrexate (MTX). This study aimed to investigate the single nucleotide polymorphisms (SNPs) of two genetic DNA markers (MTHFR 677 C and ABCC2 C), their correlation to protein expression, and laboratory investigations as potential predictors of susceptibility to MTX toxicity among patients. This is a case‐control study involving 90 patients treated with methotrexate at the Kasr Al‐Ainy psoriasis unit (KAPU), Department of Dermatology. Upon assessing genetic marker polymorphisms, the MTHFR 677 C allele was the most common among all patients (69%). There were more patients with the mutant homozygous (TT) allele in the case group compared to the control group (30% vs. 7%). The ABCC2 C allele was the most prevalent (75%), with the T allele present in 25% of patients. The case group exhibited a lower expression of the CT allele compared to the control group (30% vs. 53%), with a significant difference between the two groups. MTX levels were higher in the case group, while homocysteine levels did not differ significantly between the groups. The C allele of the ABCC2 gene, with a methotrexate cutoff greater than 4.5081 ng/ml, and the MTHFR T polymorphism are strongly associated with toxicity. The risk of toxicity in individuals receiving methotrexate can be predicted with a threshold value of 4.5081 ng/ml for methotrexate levels; however, there was no significant variation in homocysteine levels across the groups.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MethotrexateMethylenetetrahydrofolate Reductase (NADPH2)ATP-Binding Cassette, Sub-Family C ProteinsPolymorphism, Single NucleotidePsoriasisHumansMultidrug Resistance-Associated Protein 2Case-Control StudiesMaleFemaleEgyptAdultMiddle AgedGenetic MarkersAlleles

Stichwörter der Autor:innen

homocysteinemethotrexatemethotrexate levelpolymorphismpsoriasistoxicity

Substanzen

MethotrexateMultidrug Resistance-Associated Protein 2Methylenetetrahydrofolate Reductase (NADPH2)ATP-Binding Cassette, Sub-Family C ProteinsGenetic MarkersABCC2 protein, humanMTHFR protein, human

Autor:innen und Institutionen

  • Department of Forensic Medicine and Clinical Toxicology, Faculty of Medicine, Cairo University, Cairo, Egypt.
  • Department of Dermatology, Faculty of Medicine, Cairo University, Cairo, Egypt.
  • Department of Medical Biochemistry and Molecular Biology, Cairo University, Cairo, Egypt.
  • Broomfield Hospital, Chelmsford, Essex, UK.

ORCID-Profile: Asmaa Mohammad Sayed Ahmed

Förderung

  • Faculty of medicine cairo university; Cairo University & self-funded.

Zitieren

APA

Ahmed, A. M. S., Salam, M. H. A., Zohairy, E. A. F., El-Komy, M. H. M., Abdelgwad, M., Nasr, H. A., & Abouelkheir, A. R. (2025). Evaluation of Genetic Marker Polymorphisms (MTHFRC677T and ABCC2 C) for Predicting Methotrexate Toxicity in Psoriasis Patients in Egypt: A Case‐Control Study. Journal of Biochemical and Molecular Toxicology. https://doi.org/10.1002/jbt.70537

Vancouver

Ahmed AMS, Salam MHA, Zohairy EAF, El-Komy MHM, Abdelgwad M, Nasr HA, et al. Evaluation of Genetic Marker Polymorphisms (MTHFRC677T and ABCC2 C) for Predicting Methotrexate Toxicity in Psoriasis Patients in Egypt: A Case‐Control Study. Journal of Biochemical and Molecular Toxicology. 2025. doi:10.1002/jbt.70537

BibTeX
@article{Ahmed2025,
  author = {Ahmed, Asmaa Mohammad Sayed and Salam, Mervat Hamdy Abdel and Zohairy, Eman A F and El-Komy, Mohamed H M and Abdelgwad, Marwa and Nasr, Hussein A and Abouelkheir, Abrar Roshdy},
  title = {Evaluation of Genetic Marker Polymorphisms (MTHFRC677T and ABCC2 C) for Predicting Methotrexate Toxicity in Psoriasis Patients in Egypt: A Case‐Control Study},
  journal = {Journal of Biochemical and Molecular Toxicology},
  year = {2025},
  doi = {10.1002/jbt.70537}
}
Kostenlos starten →